Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy

American Journal of Neuroradiology

Volumn 20, Issue 1, 1999, Pages 117-123

  Meyerand, M Elizabeth ^a,b   Pipas, J Marc ^a   Mamourian, Alex ^a   Tosteson, Tor D ^a   Dunn, Jeffery F ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN BIOPSY; BRAIN TUMOR; CANCER GRADING; CELL TYPE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADULT; AGED; ANALYSIS OF VARIANCE; ASPARTIC ACID; ASTROCYTOMA; BIOPSY; BODY WATER; BRAIN NEOPLASMS; CHOLINE; CREATINE; FEMALE; GLIOBLASTOMA; HUMANS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 0033501045     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tedeschi G, Lundbom N, Raman R, et al. Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 1997;87:516-524
2. Rand SD, Prost R, Haughton V, et al. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from non-neoplastic brain lesions. AJNR Am J Neuroradiol 1997;18: 169-1704
3. Demacrel P, Johannik K, Van Heche P, et al. Localized H-1 NMR spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76
4. Miller BL, McBride D, Riedy G, Caron M, Lipcamon J, O'Brien D. Changes in brain choline in tumors with H-1 NMR spectroscopy. Bull Clin Neurosci 1990;55:115-122
5. Sijens PE, Knopp MV, Brunetti A, et al. H-1 spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med 1995;33:818-826
6. Bruhn H, Frahm J, Gyngell ML, et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Ra diology 1989;172:541-548
7. Poptani H, Gupta RK, Roy R, Pandey R, Jain VK, Chhabra DK. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16: 1593-1603
8. Segebarth CM, Baleriaux DF, Luvten PR, den Hollander JA. Detection of metabolic heterogeneity of human intracranial tumors in vivo by H-1 NMR spectroscopic imaging. Magn Reson Med 1990;13:62-76
9. Ott D, Hennig J, Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology 1993;186:745-752
10. Fulham MJ, Bizzi A, Diatz MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992;185:675-686
11. Yamagata NT, Miller BL, McBride D. et al. In vivo proton spectroscopv of intracranial infections and neoplasms. J Neuroimaging 1994;4:23-28
12. Negendank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-458
13. Pruel MC. Accurate noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med 1996;2:323-325
14. Go KG, Kamman RL, Mooyaart EL, et al. Localized proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography. Neuroradiology 1995;37:198-206
15. Devita VT, Hellman S, Rosenberg SA, et al. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia: Lippincott-Raven: 1997;2013-2015
16. Levin VA, Silver P, Hannigan J, et al. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG6G61 final report. Int J Radiat Oncol Biol Phys 1990;18: 321-324
17. Damjanov I, Linder J, eds. Anderson's Pathology. 9th ed. St Louis: Mosby: 1990:2168
18. Devita VT, Hellman S, Rosenberg SA, et al. Cancer: Principles and Practice af Oncology. 5th ed. Philadelphia: Lippincotl-Raven: 1997;2043-2047
19. Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GP. Metaanalysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71: 2585-2597
20. Somorjai RL, Dolenko B, Nikulin AK, et al. Classification of 1H MR spectra of human brain neoplasms: the influence of preprocessing and computerized consensus diagnosis on classification accuracy. J Magn Reson Imaging 1996;6:437-444
21. Soher BJ, Hurd RE, Sailasuta N, Barker PB. Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference. Magn Reson Med 1996;36:335-339
22. Houkin K, Kamada K, Sawamura Y, et al. Proton magnetic resonance spectroscopy (1H-MRS for the evaluation of treatment of brain tumors. Neuroradiology 1995;37:99-103
23. Chang L, McBride D, Jenden D, et al. Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimaging 1995;5:157-163
24. Posse S, Dager RS, Richards TL, et al. In vivo measurement of regional brain metabolic response to hyperventilation using magnetic resonance: proton echo planar spectroscopic imaging (PEPSI). Magn Reson Med 1997;37:858-865
25. Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993;30:1-14
26. Bovee WMMJ. Quantification of glutamate, glutamine, and other metabolites in in vivo proton NMR spectroscopy. NMR Biomed 1991;4:81-84
27. Ross BD, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994;10:191-247
28. Bottomley PA. Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? Radiology 1989;170: 1-15
29. Negandank WG, Sauter R, Brown TR, et al. Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 1996;84:449-458